APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood & Tissue Kit

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Blood & Tissue Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025195 pages

Choose your research edition.

Industry ResearchBlood & Tissue Kit Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood & Tissue Kit Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Blood & Tissue Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood & Tissue Kit Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood & Tissue Kit Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Blood & Tissue Kit market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Blood & Tissue Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Blood & Tissue Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blood & Tissue Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Blood & Tissue Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Blood & Tissue Kit include QIAGEN, Analytik Jena, Axygen (Corning), Bio-Rad, BioVision, Geneaid, Illumina, Lucigen (Biosearch Technologies) and Macherey-Nagel, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Blood & Tissue Kit market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Blood & Tissue Kit and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blood & Tissue Kit sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Blood & Tissue Kit market size, projected growth trends, production technologies, key applications, and end-use industries.

Blood & Tissue Kit Segment by Company

QIAGEN

Analytik Jena

Axygen (Corning)

Bio-Rad

BioVision

Geneaid

Illumina

Lucigen (Biosearch Technologies)

Macherey-Nagel

Norgen

Omega Bio-tek

Promega

Sigma-Aldrich (Merck)

Zymo Research

MGI Tech Co., Ltd.

Roche

Thermo Fisher Scientific

Blood & Tissue Kit Segment by Type

Buffy Coat

Whole Blood

Plasma or Serum

Blood & Tissue Kit Segment by Application

R&D Organisations

Biotechnology Companies

Blood & Tissue Kit Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood & Tissue Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood & Tissue Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood & Tissue Kit.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Blood & Tissue Kit market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Blood & Tissue Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Blood & Tissue Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Blood & Tissue Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Blood & Tissue Kit Industry Trends Table 2. Blood & Tissue Kit Industry Drivers Table 3. Blood & Tissue Kit Industry Opportunities and Challenges Table 4. Blood & Tissue Kit Industry Restraints Table 5. Global Blood & Tissue Kit Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Blood & Tissue Kit Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Blood & Tissue Kit Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Blood & Tissue Kit Sales Market Share by Manufacturers Table 9. Global Blood & Tissue Kit Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Blood & Tissue Kit Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Blood & Tissue Kit Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Blood & Tissue Kit Manufacturers, Product Type & Application Table 13. Global Blood & Tissue Kit Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Blood & Tissue Kit by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Buffy Coat Table 17. Major Manufacturers of Whole Blood Table 18. Major Manufacturers of Plasma or Serum Table 19. Global Blood & Tissue Kit Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Blood & Tissue Kit Sales by Type (2021-2026) & (K Units) Table 21. Global Blood & Tissue Kit Sales by Type (2027-2032) & (K Units) Table 22. Global Blood & Tissue Kit Sales Market Share by Type (2021-2026) Table 23. Global Blood & Tissue Kit Sales Market Share by Type (2027-2032) Table 24. Global Blood & Tissue Kit Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Blood & Tissue Kit Revenue by Type (2021-2026) & (K Units) Table 26. Global Blood & Tissue Kit Revenue by Type (2027-2032) & (K Units) Table 27. Global Blood & Tissue Kit Revenue Market Share by Type (2021-2026) Table 28. Global Blood & Tissue Kit Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of R&D Organisations Table 30. Major Manufacturers of Biotechnology Companies Table 31. Global Blood & Tissue Kit Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Blood & Tissue Kit Sales by Application (2021-2026) & (K Units) Table 33. Global Blood & Tissue Kit Sales by Application (2027-2032) & (K Units) Table 34. Global Blood & Tissue Kit Sales Market Share by Application (2021-2026) Table 35. Global Blood & Tissue Kit Sales Market Share by Application (2027-2032) Table 36. Global Blood & Tissue Kit Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Blood & Tissue Kit Revenue by Application (2021-2026) & (K Units) Table 38. Global Blood & Tissue Kit Revenue by Application (2027-2032) & (K Units) Table 39. Global Blood & Tissue Kit Revenue Market Share by Application (2021-2026) Table 40. Global Blood & Tissue Kit Revenue Market Share by Application (2027-2032) Table 41. Global Blood & Tissue Kit Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Blood & Tissue Kit Sales by Region (2021-2026) & (K Units) Table 43. Global Blood & Tissue Kit Sales Market Share by Region (2021-2026) Table 44. Global Blood & Tissue Kit Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Blood & Tissue Kit Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Blood & Tissue Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Blood & Tissue Kit Sales by Country (2021-2026) & (K Units) Table 48. North America Blood & Tissue Kit Sales by Country (2027-2032) & (K Units) Table 49. Europe Blood & Tissue Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Blood & Tissue Kit Sales by Country (2021-2026) & (K Units) Table 51. Europe Blood & Tissue Kit Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Blood & Tissue Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Blood & Tissue Kit Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Blood & Tissue Kit Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Blood & Tissue Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Blood & Tissue Kit Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Blood & Tissue Kit Sales by Country (2027-2032) & (K Units) Table 58. Global Blood & Tissue Kit Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Blood & Tissue Kit Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Blood & Tissue Kit Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Blood & Tissue Kit Revenue Market Share by Region (2021-2026) Table 62. Global Blood & Tissue Kit Revenue Market Share by Region (2027-2032) Table 63. QIAGEN Company Information Table 64. QIAGEN Business Overview Table 65. QIAGEN Blood & Tissue Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. QIAGEN Blood & Tissue Kit Product Portfolio Table 67. QIAGEN Recent Development Table 68. Analytik Jena Company Information Table 69. Analytik Jena Business Overview Table 70. Analytik Jena Blood & Tissue Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Analytik Jena Blood & Tissue Kit Product Portfolio Table 72. Analytik Jena Recent Development Table 73. Axygen (Corning) Company Information Table 74. Axygen (Corning) Business Overview Table 75. Axygen (Corning) Blood & Tissue Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Axygen (Corning) Blood & Tissue Kit Product Portfolio Table 77. Axygen (Corning) Recent Development Table 78. Bio-Rad Company Information Table 79. Bio-Rad Business Overview Table 80. Bio-Rad Blood & Tissue Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Bio-Rad Blood & Tissue Kit Product Portfolio Table 82. Bio-Rad Recent Development Table 83. BioVision Company Information Table 84. BioVision Business Overview Table 85. BioVision Blood & Tissue Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. BioVision Blood & Tissue Kit Product Portfolio Table 87. BioVision Recent Development Table 88. Geneaid Company Information Table 89. Geneaid Business Overview Table 90. Geneaid Blood & Tissue Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Geneaid Blood & Tissue Kit Product Portfolio Table 92. Geneaid Recent Development Table 93. Illumina Company Information Table 94. Illumina Business Overview Table 95. Illumina Blood & Tissue Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Illumina Blood & Tissue Kit Product Portfolio Table 97. Illumina Recent Development Table 98. Lucigen (Biosearch Technologies) Company Information Table 99. Lucigen (Biosearch Technologies) Business Overview Table 100. Lucigen (Biosearch Technologies) Blood & Tissue Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Lucigen (Biosearch Technologies) Blood & Tissue Kit Product Portfolio Table 102. Lucigen (Biosearch Technologies) Recent Development Table 103. Macherey-Nagel Company Information Table 104. Macherey-Nagel Business Overview Table 105. Macherey-Nagel Blood & Tissue Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Macherey-Nagel Blood & Tissue Kit Product Portfolio Table 107. Macherey-Nagel Recent Development Table 108. Norgen Company Information Table 109. Norgen Business Overview Table 110. Norgen Blood & Tissue Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Norgen Blood & Tissue Kit Product Portfolio Table 112. Norgen Recent Development Table 113. Omega Bio-tek Company Information Table 114. Omega Bio-tek Business Overview Table 115. Omega Bio-tek Blood & Tissue Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Omega Bio-tek Blood & Tissue Kit Product Portfolio Table 117. Omega Bio-tek Recent Development Table 118. Promega Company Information Table 119. Promega Business Overview Table 120. Promega Blood & Tissue Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Promega Blood & Tissue Kit Product Portfolio Table 122. Promega Recent Development Table 123. Sigma-Aldrich (Merck) Company Information Table 124. Sigma-Aldrich (Merck) Business Overview Table 125. Sigma-Aldrich (Merck) Blood & Tissue Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Sigma-Aldrich (Merck) Blood & Tissue Kit Product Portfolio Table 127. Sigma-Aldrich (Merck) Recent Development Table 128. Zymo Research Company Information Table 129. Zymo Research Business Overview Table 130. Zymo Research Blood & Tissue Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Zymo Research Blood & Tissue Kit Product Portfolio Table 132. Zymo Research Recent Development Table 133. MGI Tech Co., Ltd. Company Information Table 134. MGI Tech Co., Ltd. Business Overview Table 135. MGI Tech Co., Ltd. Blood & Tissue Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. MGI Tech Co., Ltd. Blood & Tissue Kit Product Portfolio Table 137. MGI Tech Co., Ltd. Recent Development Table 138. Roche Company Information Table 139. Roche Business Overview Table 140. Roche Blood & Tissue Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Roche Blood & Tissue Kit Product Portfolio Table 142. Roche Recent Development Table 143. Thermo Fisher Scientific Company Information Table 144. Thermo Fisher Scientific Business Overview Table 145. Thermo Fisher Scientific Blood & Tissue Kit Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Thermo Fisher Scientific Blood & Tissue Kit Product Portfolio Table 147. Thermo Fisher Scientific Recent Development Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Blood & Tissue Kit Distributors List Table 151. Blood & Tissue Kit Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Blood & Tissue Kit Product Image Figure 2. Global Blood & Tissue Kit Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood & Tissue Kit Market Size (2021-2032) & (US$ Million) Figure 4. Global Blood & Tissue Kit Sales (2021-2032) & (K Units) Figure 5. Global Blood & Tissue Kit Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Blood & Tissue Kit Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Buffy Coat Image Figure 9. Whole Blood Image Figure 10. Plasma or Serum Image Figure 11. Global Blood & Tissue Kit Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Blood & Tissue Kit Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Blood & Tissue Kit Sales Market Share by Type (2021-2032) Figure 14. Global Blood & Tissue Kit Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Blood & Tissue Kit Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Blood & Tissue Kit Revenue Market Share by Type (2021-2032) Figure 17. R&D Organisations Image Figure 18. Biotechnology Companies Image Figure 19. Global Blood & Tissue Kit Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Blood & Tissue Kit Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Blood & Tissue Kit Sales Market Share by Application (2021-2032) Figure 22. Global Blood & Tissue Kit Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Blood & Tissue Kit Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Blood & Tissue Kit Revenue Market Share by Application (2021-2032) Figure 25. North America Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Blood & Tissue Kit Sales Market Share by Country (2021-2032) Figure 27. U.S. Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Blood & Tissue Kit Sales Market Share by Country (2021-2032) Figure 32. Germany Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Blood & Tissue Kit Sales Market Share by Country (2021-2032) Figure 39. China Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Blood & Tissue Kit Sales Market Share by Country (2021-2032) Figure 47. Brazil Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Blood & Tissue Kit Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Blood & Tissue Kit Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Blood & Tissue Kit Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Blood & Tissue Kit Revenue (2021-2032) & (US$ Million) Figure 58. North America Blood & Tissue Kit Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Blood & Tissue Kit Revenue (2021-2032) & (US$ Million) Figure 60. Europe Blood & Tissue Kit Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Blood & Tissue Kit Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Blood & Tissue Kit Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Blood & Tissue Kit Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Blood & Tissue Kit Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Blood & Tissue Kit Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Blood & Tissue Kit Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Buffy Coat
  • Whole Blood
  • Plasma or Serum
Applications
  • R&D Organisations
  • Biotechnology Companies
Companies covered
  • QIAGEN
  • Analytik Jena
  • Axygen (Corning)
  • Bio-Rad
  • BioVision
  • Geneaid
  • Illumina
  • Lucigen (Biosearch Technologies)
  • Macherey-Nagel
  • Norgen
  • Omega Bio-tek
  • Promega
  • Sigma-Aldrich (Merck)
  • Zymo Research
  • MGI Tech Co., Ltd.
  • Roche
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Blood & Tissue Kit Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Blood & Tissue Kit Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Blood & Tissue Kit Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Blood & Tissue Kit Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Blood & Tissue Kit Market Dynamics
  1. 2.1 Blood & Tissue Kit Industry Trends
  2. 2.2 Blood & Tissue Kit Industry Drivers
  3. 2.3 Blood & Tissue Kit Industry Opportunities and Challenges
  4. 2.4 Blood & Tissue Kit Industry Restraints
3 Blood & Tissue Kit Market by Manufacturers
  1. 3.1 Global Blood & Tissue Kit Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Blood & Tissue Kit Sales by Manufacturers (2021-2026)
  3. 3.3 Global Blood & Tissue Kit Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Blood & Tissue Kit Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Blood & Tissue Kit Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Blood & Tissue Kit Manufacturers, Product Type & Application
  7. 3.7 Global Blood & Tissue Kit Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Blood & Tissue Kit Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Blood & Tissue Kit Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Blood & Tissue Kit Tier 1, Tier 2, and Tier 3
4 Blood & Tissue Kit Market by Type
  1. 4.1 Blood & Tissue Kit Type Introduction
  2. 4.1.1 Buffy Coat
  3. 4.1.2 Whole Blood
  4. 4.1.3 Plasma or Serum
  5. 4.2 Global Blood & Tissue Kit Sales by Type
  6. 4.2.1 Global Blood & Tissue Kit Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Blood & Tissue Kit Sales by Type (2021-2032)
  8. 4.2.3 Global Blood & Tissue Kit Sales Market Share by Type (2021-2032)
  9. 4.3 Global Blood & Tissue Kit Revenue by Type
  10. 4.3.1 Global Blood & Tissue Kit Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Blood & Tissue Kit Revenue by Type (2021-2032)
  12. 4.3.3 Global Blood & Tissue Kit Revenue Market Share by Type (2021-2032)
5 Blood & Tissue Kit Market by Application
  1. 5.1 Blood & Tissue Kit Application Introduction
  2. 5.1.1 R&D Organisations
  3. 5.1.2 Biotechnology Companies
  4. 5.2 Global Blood & Tissue Kit Sales by Application
  5. 5.2.1 Global Blood & Tissue Kit Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Blood & Tissue Kit Sales by Application (2021-2032)
  7. 5.2.3 Global Blood & Tissue Kit Sales Market Share by Application (2021-2032)
  8. 5.3 Global Blood & Tissue Kit Revenue by Application
  9. 5.3.1 Global Blood & Tissue Kit Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Blood & Tissue Kit Revenue by Application (2021-2032)
  11. 5.3.3 Global Blood & Tissue Kit Revenue Market Share by Application (2021-2032)
6 Global Blood & Tissue Kit Sales by Region
  1. 6.1 Global Blood & Tissue Kit Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Blood & Tissue Kit Sales by Region (2021-2032)
  3. 6.2.1 Global Blood & Tissue Kit Sales by Region (2021-2026)
  4. 6.2.2 Global Blood & Tissue Kit Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Blood & Tissue Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Blood & Tissue Kit Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Blood & Tissue Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Blood & Tissue Kit Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Blood & Tissue Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Blood & Tissue Kit Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Blood & Tissue Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Blood & Tissue Kit Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Blood & Tissue Kit Revenue by Region
  1. 7.1 Global Blood & Tissue Kit Revenue by Region
  2. 7.1.1 Global Blood & Tissue Kit Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Blood & Tissue Kit Revenue by Region (2021-2026)
  4. 7.1.3 Global Blood & Tissue Kit Revenue by Region (2027-2032)
  5. 7.1.4 Global Blood & Tissue Kit Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Blood & Tissue Kit Revenue (2021-2032)
  8. 7.2.2 North America Blood & Tissue Kit Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Blood & Tissue Kit Revenue (2021-2032)
  11. 7.3.2 Europe Blood & Tissue Kit Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Blood & Tissue Kit Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Blood & Tissue Kit Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Blood & Tissue Kit Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Blood & Tissue Kit Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 QIAGEN
  2. 8.1.1 QIAGEN Company Information
  3. 8.1.2 QIAGEN Business Overview
  4. 8.1.3 QIAGEN Blood & Tissue Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 QIAGEN Blood & Tissue Kit Product Portfolio
  6. 8.1.5 QIAGEN Recent Developments
  7. 8.2 Analytik Jena
  8. 8.2.1 Analytik Jena Company Information
  9. 8.2.2 Analytik Jena Business Overview
  10. 8.2.3 Analytik Jena Blood & Tissue Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Analytik Jena Blood & Tissue Kit Product Portfolio
  12. 8.2.5 Analytik Jena Recent Developments
  13. 8.3 Axygen (Corning)
  14. 8.3.1 Axygen (Corning) Company Information
  15. 8.3.2 Axygen (Corning) Business Overview
  16. 8.3.3 Axygen (Corning) Blood & Tissue Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Axygen (Corning) Blood & Tissue Kit Product Portfolio
  18. 8.3.5 Axygen (Corning) Recent Developments
  19. 8.4 Bio-Rad
  20. 8.4.1 Bio-Rad Company Information
  21. 8.4.2 Bio-Rad Business Overview
  22. 8.4.3 Bio-Rad Blood & Tissue Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bio-Rad Blood & Tissue Kit Product Portfolio
  24. 8.4.5 Bio-Rad Recent Developments
  25. 8.5 BioVision
  26. 8.5.1 BioVision Company Information
  27. 8.5.2 BioVision Business Overview
  28. 8.5.3 BioVision Blood & Tissue Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 BioVision Blood & Tissue Kit Product Portfolio
  30. 8.5.5 BioVision Recent Developments
  31. 8.6 Geneaid
  32. 8.6.1 Geneaid Company Information
  33. 8.6.2 Geneaid Business Overview
  34. 8.6.3 Geneaid Blood & Tissue Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Geneaid Blood & Tissue Kit Product Portfolio
  36. 8.6.5 Geneaid Recent Developments
  37. 8.7 Illumina
  38. 8.7.1 Illumina Company Information
  39. 8.7.2 Illumina Business Overview
  40. 8.7.3 Illumina Blood & Tissue Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Illumina Blood & Tissue Kit Product Portfolio
  42. 8.7.5 Illumina Recent Developments
  43. 8.8 Lucigen (Biosearch Technologies)
  44. 8.8.1 Lucigen (Biosearch Technologies) Company Information
  45. 8.8.2 Lucigen (Biosearch Technologies) Business Overview
  46. 8.8.3 Lucigen (Biosearch Technologies) Blood & Tissue Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lucigen (Biosearch Technologies) Blood & Tissue Kit Product Portfolio
  48. 8.8.5 Lucigen (Biosearch Technologies) Recent Developments
  49. 8.9 Macherey-Nagel
  50. 8.9.1 Macherey-Nagel Company Information
  51. 8.9.2 Macherey-Nagel Business Overview
  52. 8.9.3 Macherey-Nagel Blood & Tissue Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Macherey-Nagel Blood & Tissue Kit Product Portfolio
  54. 8.9.5 Macherey-Nagel Recent Developments
  55. 8.10 Norgen
  56. 8.10.1 Norgen Company Information
  57. 8.10.2 Norgen Business Overview
  58. 8.10.3 Norgen Blood & Tissue Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Norgen Blood & Tissue Kit Product Portfolio
  60. 8.10.5 Norgen Recent Developments
  61. 8.11 Omega Bio-tek
  62. 8.11.1 Omega Bio-tek Company Information
  63. 8.11.2 Omega Bio-tek Business Overview
  64. 8.11.3 Omega Bio-tek Blood & Tissue Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Omega Bio-tek Blood & Tissue Kit Product Portfolio
  66. 8.11.5 Omega Bio-tek Recent Developments
  67. 8.12 Promega
  68. 8.12.1 Promega Company Information
  69. 8.12.2 Promega Business Overview
  70. 8.12.3 Promega Blood & Tissue Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Promega Blood & Tissue Kit Product Portfolio
  72. 8.12.5 Promega Recent Developments
  73. 8.13 Sigma-Aldrich (Merck)
  74. 8.13.1 Sigma-Aldrich (Merck) Company Information
  75. 8.13.2 Sigma-Aldrich (Merck) Business Overview
  76. 8.13.3 Sigma-Aldrich (Merck) Blood & Tissue Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sigma-Aldrich (Merck) Blood & Tissue Kit Product Portfolio
  78. 8.13.5 Sigma-Aldrich (Merck) Recent Developments
  79. 8.14 Zymo Research
  80. 8.14.1 Zymo Research Company Information
  81. 8.14.2 Zymo Research Business Overview
  82. 8.14.3 Zymo Research Blood & Tissue Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Zymo Research Blood & Tissue Kit Product Portfolio
  84. 8.14.5 Zymo Research Recent Developments
  85. 8.15 MGI Tech Co., Ltd.
  86. 8.15.1 MGI Tech Co., Ltd. Company Information
  87. 8.15.2 MGI Tech Co., Ltd. Business Overview
  88. 8.15.3 MGI Tech Co., Ltd. Blood & Tissue Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 MGI Tech Co., Ltd. Blood & Tissue Kit Product Portfolio
  90. 8.15.5 MGI Tech Co., Ltd. Recent Developments
  91. 8.16 Roche
  92. 8.16.1 Roche Company Information
  93. 8.16.2 Roche Business Overview
  94. 8.16.3 Roche Blood & Tissue Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Roche Blood & Tissue Kit Product Portfolio
  96. 8.16.5 Roche Recent Developments
  97. 8.17 Thermo Fisher Scientific
  98. 8.17.1 Thermo Fisher Scientific Company Information
  99. 8.17.2 Thermo Fisher Scientific Business Overview
  100. 8.17.3 Thermo Fisher Scientific Blood & Tissue Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Thermo Fisher Scientific Blood & Tissue Kit Product Portfolio
  102. 8.17.5 Thermo Fisher Scientific Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Blood & Tissue Kit Value Chain Analysis
  2. 9.1.1 Blood & Tissue Kit Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Blood & Tissue Kit Production Mode & Process
  6. 9.2 Blood & Tissue Kit Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Blood & Tissue Kit Distributors
  9. 9.2.3 Blood & Tissue Kit Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst